A Prospective, Multi-center, Open-label, Single Arm Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II DIAbetic patieNTs With Suboptimal Blood Pressure Control
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2014
At a glance
- Drugs Bisoprolol (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- Acronyms GIANT
- Sponsors Merck KGaA
- 10 Jun 2017 Biomarkers information updated
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2013 Planned end date changed from 1 Mar 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.